CATHERINE PHILLIPS: Open Payments
NPI 1750373999 · HASTINGS, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,061 in 67 payments from 13 companies in 2025. Trend: 2023 $639 · 2024 $734 · 2025 $1,061
Food & beverage: $1,061
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $242 |
| Janssen Pharmaceuticals, Inc | 11 | $151 |
| Neurocrine BioSciences, Inc. | 9 | $133 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $117 |
| Otsuka America Pharmaceutical, Inc. | 5 | $83 |
| Teva Pharmaceuticals USA, Inc. | 4 | $81 |
| Collegium Pharmaceutical, Inc. | 3 | $62 |
| Alkermes, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 3 | $42 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
Products named: VRAYLAR, INGREZZA, CAPLYTA, INVEGA SUSTENNA, REXULTI, Jornay PM, SPRAVATO, AUSTEDO XR.
Industry payments across NE — which companies pay providers there.
